世界の外部神経調節市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global External Neuromodulation Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2284 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、外部神経調節のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経皮的電気刺激、経頭蓋磁気刺激、呼吸電気刺激）、用途別市場規模（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・外部神経調節の市場動向 ・企業の競争状況、市場シェア ・外部神経調節の種類別市場規模（経皮的電気刺激、経頭蓋磁気刺激、呼吸電気刺激） ・外部神経調節の用途別市場規模（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、その他） ・外部神経調節の北米市場規模2016-2027（アメリカ、カナダ） ・外部神経調節のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・外部神経調節のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・外部神経調節の中南米市場規模2016-2027（メキシコ、ブラジル） ・外部神経調節の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medtronic, Inc. (US)、Boston Scientific Corporation (US)、St. Jude Medical, Inc. (US)、Synapse Biomedical, Inc. (US)、Nevro Corporation (US)、Neurosigma, Inc. (US)、Neuropace, Inc. (US)、Neuronetics, Inc. (US)、Cyberonics, Inc. (US)、BioControl Medical (Israel)） ・結論

Market Analysis and Insights: Global External Neuromodulation Market
The global External Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global External Neuromodulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global External Neuromodulation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global External Neuromodulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global External Neuromodulation market.

Global External Neuromodulation Scope and Market Size
External Neuromodulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global External Neuromodulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation

Segment by Application
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global External Neuromodulation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transcutaneous Electrical Nerve Stimulation
1.2.3 Transcranial Magnetic Stimulation
1.2.4 Respiratory Electrical Stimulation
1.3 Market by Application
1.3.1 Global External Neuromodulation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global External Neuromodulation Market Perspective (2016-2027)
2.2 External Neuromodulation Growth Trends by Regions
2.2.1 External Neuromodulation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 External Neuromodulation Historic Market Share by Regions (2016-2021)
2.2.3 External Neuromodulation Forecasted Market Size by Regions (2022-2027)
2.3 External Neuromodulation Industry Dynamic
2.3.1 External Neuromodulation Market Trends
2.3.2 External Neuromodulation Market Drivers
2.3.3 External Neuromodulation Market Challenges
2.3.4 External Neuromodulation Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top External Neuromodulation Players by Revenue
3.1.1 Global Top External Neuromodulation Players by Revenue (2016-2021)
3.1.2 Global External Neuromodulation Revenue Market Share by Players (2016-2021)
3.2 Global External Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by External Neuromodulation Revenue
3.4 Global External Neuromodulation Market Concentration Ratio
3.4.1 Global External Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by External Neuromodulation Revenue in 2020
3.5 External Neuromodulation Key Players Head office and Area Served
3.6 Key Players External Neuromodulation Product Solution and Service
3.7 Date of Enter into External Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans

4 External Neuromodulation Breakdown Data by Type
4.1 Global External Neuromodulation Historic Market Size by Type (2016-2021)
4.2 Global External Neuromodulation Forecasted Market Size by Type (2022-2027)

5 External Neuromodulation Breakdown Data by Application
5.1 Global External Neuromodulation Historic Market Size by Application (2016-2021)
5.2 Global External Neuromodulation Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America External Neuromodulation Market Size (2016-2027)
6.2 North America External Neuromodulation Market Size by Type
6.2.1 North America External Neuromodulation Market Size by Type (2016-2021)
6.2.2 North America External Neuromodulation Market Size by Type (2022-2027)
6.2.3 North America External Neuromodulation Market Size by Type (2016-2027)
6.3 North America External Neuromodulation Market Size by Application
6.3.1 North America External Neuromodulation Market Size by Application (2016-2021)
6.3.2 North America External Neuromodulation Market Size by Application (2022-2027)
6.3.3 North America External Neuromodulation Market Size by Application (2016-2027)
6.4 North America External Neuromodulation Market Size by Country
6.4.1 North America External Neuromodulation Market Size by Country (2016-2021)
6.4.2 North America External Neuromodulation Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe External Neuromodulation Market Size (2016-2027)
7.2 Europe External Neuromodulation Market Size by Type
7.2.1 Europe External Neuromodulation Market Size by Type (2016-2021)
7.2.2 Europe External Neuromodulation Market Size by Type (2022-2027)
7.2.3 Europe External Neuromodulation Market Size by Type (2016-2027)
7.3 Europe External Neuromodulation Market Size by Application
7.3.1 Europe External Neuromodulation Market Size by Application (2016-2021)
7.3.2 Europe External Neuromodulation Market Size by Application (2022-2027)
7.3.3 Europe External Neuromodulation Market Size by Application (2016-2027)
7.4 Europe External Neuromodulation Market Size by Country
7.4.1 Europe External Neuromodulation Market Size by Country (2016-2021)
7.4.2 Europe External Neuromodulation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific External Neuromodulation Market Size (2016-2027)
8.2 Asia-Pacific External Neuromodulation Market Size by Type
8.2.1 Asia-Pacific External Neuromodulation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific External Neuromodulation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific External Neuromodulation Market Size by Type (2016-2027)
8.3 Asia-Pacific External Neuromodulation Market Size by Application
8.3.1 Asia-Pacific External Neuromodulation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific External Neuromodulation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific External Neuromodulation Market Size by Application (2016-2027)
8.4 Asia-Pacific External Neuromodulation Market Size by Region
8.4.1 Asia-Pacific External Neuromodulation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific External Neuromodulation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America External Neuromodulation Market Size (2016-2027)
9.2 Latin America External Neuromodulation Market Size by Type
9.2.1 Latin America External Neuromodulation Market Size by Type (2016-2021)
9.2.2 Latin America External Neuromodulation Market Size by Type (2022-2027)
9.2.3 Latin America External Neuromodulation Market Size by Type (2016-2027)
9.3 Latin America External Neuromodulation Market Size by Application
9.3.1 Latin America External Neuromodulation Market Size by Application (2016-2021)
9.3.2 Latin America External Neuromodulation Market Size by Application (2022-2027)
9.3.3 Latin America External Neuromodulation Market Size by Application (2016-2027)
9.4 Latin America External Neuromodulation Market Size by Country
9.4.1 Latin America External Neuromodulation Market Size by Country (2016-2021)
9.4.2 Latin America External Neuromodulation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa External Neuromodulation Market Size (2016-2027)
10.2 Middle East & Africa External Neuromodulation Market Size by Type
10.2.1 Middle East & Africa External Neuromodulation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa External Neuromodulation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa External Neuromodulation Market Size by Type (2016-2027)
10.3 Middle East & Africa External Neuromodulation Market Size by Application
10.3.1 Middle East & Africa External Neuromodulation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa External Neuromodulation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa External Neuromodulation Market Size by Application (2016-2027)
10.4 Middle East & Africa External Neuromodulation Market Size by Country
10.4.1 Middle East & Africa External Neuromodulation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa External Neuromodulation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Medtronic, Inc. (US)
11.1.1 Medtronic, Inc. (US) Company Details
11.1.2 Medtronic, Inc. (US) Business Overview
11.1.3 Medtronic, Inc. (US) External Neuromodulation Introduction
11.1.4 Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2016-2021)
11.1.5 Medtronic, Inc. (US) Recent Development
11.2 Boston Scientific Corporation (US)
11.2.1 Boston Scientific Corporation (US) Company Details
11.2.2 Boston Scientific Corporation (US) Business Overview
11.2.3 Boston Scientific Corporation (US) External Neuromodulation Introduction
11.2.4 Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2016-2021)
11.2.5 Boston Scientific Corporation (US) Recent Development
11.3 St. Jude Medical, Inc. (US)
11.3.1 St. Jude Medical, Inc. (US) Company Details
11.3.2 St. Jude Medical, Inc. (US) Business Overview
11.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Introduction
11.3.4 St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2016-2021)
11.3.5 St. Jude Medical, Inc. (US) Recent Development
11.4 Synapse Biomedical, Inc. (US)
11.4.1 Synapse Biomedical, Inc. (US) Company Details
11.4.2 Synapse Biomedical, Inc. (US) Business Overview
11.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Introduction
11.4.4 Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2016-2021)
11.4.5 Synapse Biomedical, Inc. (US) Recent Development
11.5 Nevro Corporation (US)
11.5.1 Nevro Corporation (US) Company Details
11.5.2 Nevro Corporation (US) Business Overview
11.5.3 Nevro Corporation (US) External Neuromodulation Introduction
11.5.4 Nevro Corporation (US) Revenue in External Neuromodulation Business (2016-2021)
11.5.5 Nevro Corporation (US) Recent Development
11.6 Neurosigma, Inc. (US)
11.6.1 Neurosigma, Inc. (US) Company Details
11.6.2 Neurosigma, Inc. (US) Business Overview
11.6.3 Neurosigma, Inc. (US) External Neuromodulation Introduction
11.6.4 Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2016-2021)
11.6.5 Neurosigma, Inc. (US) Recent Development
11.7 Neuropace, Inc. (US)
11.7.1 Neuropace, Inc. (US) Company Details
11.7.2 Neuropace, Inc. (US) Business Overview
11.7.3 Neuropace, Inc. (US) External Neuromodulation Introduction
11.7.4 Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2016-2021)
11.7.5 Neuropace, Inc. (US) Recent Development
11.8 Neuronetics, Inc. (US)
11.8.1 Neuronetics, Inc. (US) Company Details
11.8.2 Neuronetics, Inc. (US) Business Overview
11.8.3 Neuronetics, Inc. (US) External Neuromodulation Introduction
11.8.4 Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2016-2021)
11.8.5 Neuronetics, Inc. (US) Recent Development
11.9 Cyberonics, Inc. (US)
11.9.1 Cyberonics, Inc. (US) Company Details
11.9.2 Cyberonics, Inc. (US) Business Overview
11.9.3 Cyberonics, Inc. (US) External Neuromodulation Introduction
11.9.4 Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2016-2021)
11.9.5 Cyberonics, Inc. (US) Recent Development
11.10 BioControl Medical (Israel)
11.10.1 BioControl Medical (Israel) Company Details
11.10.2 BioControl Medical (Israel) Business Overview
11.10.3 BioControl Medical (Israel) External Neuromodulation Introduction
11.10.4 BioControl Medical (Israel) Revenue in External Neuromodulation Business (2016-2021)
11.10.5 BioControl Medical (Israel) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global External Neuromodulation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transcutaneous Electrical Nerve Stimulation
Table 3. Key Players of Transcranial Magnetic Stimulation
Table 4. Key Players of Respiratory Electrical Stimulation
Table 5. Global External Neuromodulation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global External Neuromodulation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global External Neuromodulation Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global External Neuromodulation Market Share by Regions (2016-2021)
Table 9. Global External Neuromodulation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global External Neuromodulation Market Share by Regions (2022-2027)
Table 11. External Neuromodulation Market Trends
Table 12. External Neuromodulation Market Drivers
Table 13. External Neuromodulation Market Challenges
Table 14. External Neuromodulation Market Restraints
Table 15. Global External Neuromodulation Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global External Neuromodulation Market Share by Players (2016-2021)
Table 17. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in External Neuromodulation as of 2020)
Table 18. Ranking of Global Top External Neuromodulation Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by External Neuromodulation Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players External Neuromodulation Product Solution and Service
Table 22. Date of Enter into External Neuromodulation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global External Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 25. Global External Neuromodulation Revenue Market Share by Type (2016-2021)
Table 26. Global External Neuromodulation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global External Neuromodulation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global External Neuromodulation Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global External Neuromodulation Revenue Market Share by Application (2016-2021)
Table 30. Global External Neuromodulation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global External Neuromodulation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America External Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 33. North America External Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America External Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 35. North America External Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America External Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America External Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe External Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe External Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe External Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe External Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe External Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe External Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific External Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific External Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific External Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific External Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific External Neuromodulation Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific External Neuromodulation Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America External Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America External Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America External Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America External Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America External Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America External Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa External Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa External Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa External Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa External Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa External Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa External Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 62. Medtronic, Inc. (US) Company Details
Table 63. Medtronic, Inc. (US) Business Overview
Table 64. Medtronic, Inc. (US) External Neuromodulation Product
Table 65. Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 66. Medtronic, Inc. (US) Recent Development
Table 67. Boston Scientific Corporation (US) Company Details
Table 68. Boston Scientific Corporation (US) Business Overview
Table 69. Boston Scientific Corporation (US) External Neuromodulation Product
Table 70. Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 71. Boston Scientific Corporation (US) Recent Development
Table 72. St. Jude Medical, Inc. (US) Company Details
Table 73. St. Jude Medical, Inc. (US) Business Overview
Table 74. St. Jude Medical, Inc. (US) External Neuromodulation Product
Table 75. St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 76. St. Jude Medical, Inc. (US) Recent Development
Table 77. Synapse Biomedical, Inc. (US) Company Details
Table 78. Synapse Biomedical, Inc. (US) Business Overview
Table 79. Synapse Biomedical, Inc. (US) External Neuromodulation Product
Table 80. Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 81. Synapse Biomedical, Inc. (US) Recent Development
Table 82. Nevro Corporation (US) Company Details
Table 83. Nevro Corporation (US) Business Overview
Table 84. Nevro Corporation (US) External Neuromodulation Product
Table 85. Nevro Corporation (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 86. Nevro Corporation (US) Recent Development
Table 87. Neurosigma, Inc. (US) Company Details
Table 88. Neurosigma, Inc. (US) Business Overview
Table 89. Neurosigma, Inc. (US) External Neuromodulation Product
Table 90. Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 91. Neurosigma, Inc. (US) Recent Development
Table 92. Neuropace, Inc. (US) Company Details
Table 93. Neuropace, Inc. (US) Business Overview
Table 94. Neuropace, Inc. (US) External Neuromodulation Product
Table 95. Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 96. Neuropace, Inc. (US) Recent Development
Table 97. Neuronetics, Inc. (US) Company Details
Table 98. Neuronetics, Inc. (US) Business Overview
Table 99. Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 100. Neuronetics, Inc. (US) Recent Development
Table 101. Cyberonics, Inc. (US) Company Details
Table 102. Cyberonics, Inc. (US) Business Overview
Table 103. Cyberonics, Inc. (US) External Neuromodulation Product
Table 104. Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 105. Cyberonics, Inc. (US) Recent Development
Table 106. BioControl Medical (Israel) Company Details
Table 107. BioControl Medical (Israel) Business Overview
Table 108. BioControl Medical (Israel) External Neuromodulation Product
Table 109. BioControl Medical (Israel) Revenue in External Neuromodulation Business (2016-2021) & (US$ Million)
Table 110. BioControl Medical (Israel) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global External Neuromodulation Market Share by Type: 2020 VS 2027
Figure 2. Transcutaneous Electrical Nerve Stimulation Features
Figure 3. Transcranial Magnetic Stimulation Features
Figure 4. Respiratory Electrical Stimulation Features
Figure 5. Global External Neuromodulation Market Share by Application: 2020 VS 2027
Figure 6. Spinal Cord Stimulation Case Studies
Figure 7. Deep Brain Stimulation Case Studies
Figure 8. Sacral Nerve Stimulation Case Studies
Figure 9. Others Case Studies
Figure 10. External Neuromodulation Report Years Considered
Figure 11. Global External Neuromodulation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global External Neuromodulation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global External Neuromodulation Market Share by Regions: 2020 VS 2027
Figure 14. Global External Neuromodulation Market Share by Regions (2022-2027)
Figure 15. Global External Neuromodulation Market Share by Players in 2020
Figure 16. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in External Neuromodulation as of 2020
Figure 17. The Top 10 and 5 Players Market Share by External Neuromodulation Revenue in 2020
Figure 18. Global External Neuromodulation Revenue Market Share by Type (2016-2021)
Figure 19. Global External Neuromodulation Revenue Market Share by Type (2022-2027)
Figure 20. North America External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America External Neuromodulation Market Share by Type (2016-2027)
Figure 22. North America External Neuromodulation Market Share by Application (2016-2027)
Figure 23. North America External Neuromodulation Market Share by Country (2016-2027)
Figure 24. United States External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe External Neuromodulation Market Share by Type (2016-2027)
Figure 28. Europe External Neuromodulation Market Share by Application (2016-2027)
Figure 29. Europe External Neuromodulation Market Share by Country (2016-2027)
Figure 30. Germany External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific External Neuromodulation Market Share by Type (2016-2027)
Figure 38. Asia-Pacific External Neuromodulation Market Share by Application (2016-2027)
Figure 39. Asia-Pacific External Neuromodulation Market Share by Region (2016-2027)
Figure 40. China External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America External Neuromodulation Market Share by Type (2016-2027)
Figure 48. Latin America External Neuromodulation Market Share by Application (2016-2027)
Figure 49. Latin America External Neuromodulation Market Share by Country (2016-2027)
Figure 50. Mexico External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa External Neuromodulation Market Share by Type (2016-2027)
Figure 54. Middle East & Africa External Neuromodulation Market Share by Application (2016-2027)
Figure 55. Middle East & Africa External Neuromodulation Market Share by Country (2016-2027)
Figure 56. Turkey External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE External Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Medtronic, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 60. Boston Scientific Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 61. St. Jude Medical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 62. Synapse Biomedical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 63. Nevro Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 64. Neurosigma, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 65. Neuropace, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 66. Neuronetics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 67. Cyberonics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 68. BioControl Medical (Israel) Revenue Growth Rate in External Neuromodulation Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---